BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 2801217)

  • 1. Opsonophagocytosis of bacteria studied by chemiluminescence in microtitre plates.
    Hastings JG; Jewes LA; Oxley KM
    J Biolumin Chemilumin; 1989 Jul; 4(1):267-71. PubMed ID: 2801217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum bactericidal activity and phagocytosis in host defence against Haemophilus ducreyi.
    Lagergård T; Frisk A; Purvèn M; Nilsson LA
    Microb Pathog; 1995 Jan; 18(1):37-51. PubMed ID: 7783597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement of phagocyte chemiluminescence using a microtitre plate luminometer.
    Blair AL; Cree IA; Beck JS
    J Biolumin Chemilumin; 1989; 3(2):67-70. PubMed ID: 2728914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding of C-reactive protein to the pneumococcal capsule or cell wall results in differential localization of C3 and stimulation of phagocytosis.
    Holzer TJ; Edwards KM; Gewurz H; Mold C
    J Immunol; 1984 Sep; 133(3):1424-30. PubMed ID: 6747291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of urine and urine components on the chemiluminescent response of bacteria-stimulated polymorphonuclear leukocytes.
    Etzioni A; Obedeanu N; Levy Y; Merzbach D; Benderly A; Shehadeh N
    Isr J Med Sci; 1991 Jul; 27(7):369-74. PubMed ID: 2071372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of extracellular slime in opsonophagocytosis of Staphylococcus epidermidis.
    Kristinsson KG; Hastings JG; Spencer RC
    J Med Microbiol; 1988 Nov; 27(3):207-13. PubMed ID: 3193443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of a microtitre plate chemiluminescence reader to study surface phagocytosis by human monocytes.
    Cree IA; Blair AL; Beck JS
    J Biolumin Chemilumin; 1989; 3(2):71-4. PubMed ID: 2728915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opsonization of encapsulated Staphylococcus aureus: the role of specific antibody and complement.
    Verbrugh HA; Peterson PK; Nguyen BY; Sisson SP; Kim Y
    J Immunol; 1982 Oct; 129(4):1681-7. PubMed ID: 7108223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of whole blood neutrophil chemiluminescence measured with cuvette and microtitre plate luminometers.
    Lojek A; Kubala L; Cízová H; Cíz M
    Luminescence; 2002; 17(1):1-4. PubMed ID: 11816055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of opsonophagocytosis mediated by specific antibodies on the co-amoxiclav serum bactericidal activity against Streptococcus pneumoniae after administration of a single oral dose of pharmacokinetically enhanced 2000/125 mg co-amoxiclav to healthy volunteers.
    Alou L; Aguilar L; Sevillano D; Giménez MJ; Laguna B; Echeverría O; Carcas A; Lubomirov R; Casal J; Prieto J
    J Antimicrob Chemother; 2005 May; 55(5):742-7. PubMed ID: 15761068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The chemiluminescence response of normal human leukocytes to chlamydia trachomatis.
    Robinson P; Wakefield D; Graham DM; Easter JF; Penny R
    Diagn Immunol; 1985; 3(3):119-25. PubMed ID: 4053494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of in vitro immune complexes on polymorphonuclear leukocyte chemiluminescence.
    Doll NJ; Salvaggio JE
    Allergol Immunopathol (Madr); 1982; 10(3):205-10. PubMed ID: 6183961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring of polymorphonuclear leukocyte functions in diabetes mellitus--a comparative study of conventional radiometric function tests and low-light imaging systems.
    Marhoffer W; Stein M; Schleinkofer L; Federlin K
    J Biolumin Chemilumin; 1994; 9(3):165-70. PubMed ID: 7942121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of C3b/C3bi opsonization and chemiluminescence with selected yeasts and bacteria using sera of different opsonic potential.
    Turner MW; Grant C; Seymour ND; Harvey B; Levinsky RJ
    Immunology; 1986 May; 58(1):111-5. PubMed ID: 3519441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutrophil chemiluminescence in burned patients.
    Sheng ZY; Tung YL
    J Trauma; 1987 Jun; 27(6):587-95. PubMed ID: 3599105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does the appearance of drug resistance during therapy alter bacterial susceptibility to opsonophagocytosis?
    Gemmell CG
    Drugs Exp Clin Res; 1996; 22(2):51-5. PubMed ID: 8879979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factor affecting the in vitro assessment of opsonization: a study of the kinetics of opsonization using the technique of phagocytic chemiluminescence.
    Williams AJ; Hastings MJ; Easmon CS; Cole PJ
    Immunology; 1980 Dec; 41(4):903-11. PubMed ID: 7007217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strain differences in the susceptibility and resistance of Pasteurella multocida to phagocytosis and killing by rabbit polymorphonuclear neutrophils.
    Anderson LC; Rush HG; Glorioso JC
    Am J Vet Res; 1984 Jun; 45(6):1193-8. PubMed ID: 6742581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A rapid and simple method for evaluation of serum opsonic capacity against Bordetella pertussis by chemiluminescence.
    Lilius EM; Mertsola J; Leivo P; Kuronen T; Ruuskanen O
    Dev Biol Stand; 1985; 61():373-7. PubMed ID: 2872125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement of phagocyte chemiluminescence in a microtitre plate format.
    Blair AL; Cree IA; Beck JS; Hastings MJ
    J Immunol Methods; 1988 Sep; 112(2):163-8. PubMed ID: 3418125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.